Article
Essential genetic mutations impair DNA damage repair and modulate tumor immune microenvironment in ccRCC.
MedScience - 1 Apr 2026
He Hongchao, Liu Xian-De, Jonasch Eric
Abstract excerpt
Targeting DNA repair defects has shown therapeutic benefits in solid tumors with genetic mutations that disrupt DNA damage repair (DDR) pathways. Clear cell renal cell carcinoma (ccRCC) demonstrates an intermediate level of genomic instability, while it rarely carries mutations in these genes. Instead, it is characterized by the loss of chromosome 3p, the von Hippel-Lindau (VHL) tumor suppressor gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
